Loading company…
Pilot Gene Technologies makes digital PCR detection systems, consumables and reagents for life science research.
Founded in 2014 and based in Hangzhou, China, the company develops life science products and held more than 80 intellectual property rights as of 2023. Its digital PCR detection systems, consumables and reagents serve pathogen detection, tumor liquid biopsy and reproduction and genetics. In September 2023 it raised about CNY 100 million in Series B funding led by new investor Hangzhou Simiao Equity Investment. The funds are earmarked for automatic instruments, POCT equipment and overseas business.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in